NCT06347718View on ClinicalTrials.gov

CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 17, 2023

Primary Completion Date

May 31, 2026

Study Completion Date

May 31, 2026

Conditions
Systemic Lupus ErythematosusSystemic SclerosisDermatomyositisPolymyositis
Interventions
DRUG

anti-CD19 CAR T cell therapy

Single-dose

Trial Locations (1)

91054

RECRUITING

Universitätsklinikum Erlangen, Erlangen

Sponsors
All Listed Sponsors
lead

Miltenyi Biomedicine GmbH

INDUSTRY